The Technical Analyst
Definitive Healthcare [DH]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Definitive Healthcare Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-2.09% $7.04
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 829.24 mill |
| EPS: | -1.790 |
| P/E: | -3.93 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 117.79 mill |
| Avg Daily Volume: | 0.511 mill |
| RATING 2024-04-18 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.93 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -3.93 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$13.82 (96.28%) $6.78 |
| Date: 2024-04-18 |
| Expected Trading Range (DAY) |
|---|
|
$ 6.67 - 7.41 ( +/- 5.20%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-14 | Booth Richard Douglas | Sell | 993 | Class A Common Stock |
| 2024-03-14 | Shamsuddin Kate Marie | Sell | 1 044 | Class A Common Stock |
| 2024-03-14 | Krantz Jason Ronald | Sell | 2 808 | Class A Common Stock |
| 2024-02-14 | Krantz Jason Ronald | Buy | 417 752 | Class A Common Stock |
| 2024-02-16 | Krantz Jason Ronald | Sell | 5 419 | Class A Common Stock |
| INSIDER POWER |
|---|
| -34.31 |
| Last 95 transactions |
| Buy: 15 214 875 | Sell: 30 177 982 |
Forecast:
16:00 - $7.04
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $7.04
Forecast 2: 16:00 - $7.04
Forecast 3: 16:00 - $7.04
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $7.04 (-2.09% ) |
| Volume | 0.398 mill |
| Avg. Vol. | 0.511 mill |
| % of Avg. Vol | 77.84 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | buy | $9.07 | N/A | Active |
|---|
DH
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Latest Press Releases
2024-03-22 09:30:00 - Press Release
Vml And Definitive Healthcare Announce Partnership To transform Key Opinion Leader Management
Partnership offers solution to streamline engagement between pharmaceutical companies and kols to help increase the value of the clinical collaborations and conversations partnership offers solution to streamline engagement between pharmaceutical companies and kols to help increase the value of the clinical collaborations and conversations
2024-03-14 15:53:00 - Press Release
Definitive Healthcare Earns 2024 Middle Market Leader Award From Boston Business Journal
Framingham, mass., march 14, 2024 (globe newswire) -- definitive healthcare (nasdaq: dh ), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the boston business journal's middle market leaders for 2024, a ranking of the 50 highest growth companies in massachusetts. this marks the second year in a row that definitive healthcare has won this award.
2024-02-28 16:05:00 - Press Release
Definitive Healthcare Reports Financial Results For Fourth Quarter And Full Fiscal Year 2023
Fourth quarter revenue grew 9% year-over-year to $65.9 million full year 2023 revenue grew 13% year-over-year to $251.4 million framingham, mass., feb. 28, 2024 (globe newswire) -- definitive healthcare corp. (“definitive healthcare” or the “company”) (nasdaq: dh), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended december 31, 2023.
2024-02-14 16:05:00 - Press Release
Definitive Healthcare Announces Timing Of Its Fourth Quarter And Full Year 2023 Financial Results Conference Call And Webcast
Framingham, mass., feb. 14, 2024 (globe newswire) -- definitive healthcare corp. (“definitive healthcare”) (nasdaq: dh), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended december 31, 2023, on wednesday, february 28, 2024 after market close. the company will host a conference call and webcast at 5:00 pm (et) / 2:00 pm (pt) to discuss the company's financial results.
2024-01-16 16:05:00 - Press Release
Definitive Healthcare Announces Ceo Transition
Jason krantz, founder and executive chairman, to serve as interim ceo company reaffirms fourth quarter 2023 guidance and issues preliminary guidance for 2024 framingham, mass., jan. 16, 2024 (globe newswire) -- definitive healthcare (nasdaq: dh) (the “company”), an industry leader in healthcare commercial intelligence, today announced that robert musslewhite has stepped down as chief executive officer and as a member of the board of directors to transition to a new phase of leadership for the company.
Latest News
2024-02-28 21:43:06 - Seeking Alpha
Definitive Healthcare Corp. (DH) Q4 2023 Earnings Call Transcript
2024-02-14 16:05:00 - GlobeNewsWire
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
2024-01-30 10:56:11 - Zacks Investment Research
Definitive Healthcare Corp. (DH) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Definitive Healthcare Corp. (DH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
2023-11-14 10:41:59 - Seeking Alpha
Definitive Healthcare: Undervalued Vs. Peers Given Revenue Growth And Margin Expansion
Strengthening fundamentals: Definitive Healthcare shows steady revenue growth at 10% and expanding adjusted EBITDA margins. CRPO growth is slowing to a controlled rate and stabilizing, which indicates the end of client churn that took place over past 2 years. Valuation outlook: Fair price potential around $9.0, signaling a 25% upside from current $7.18.
2023-10-20 09:46:43 - Zacks Investment Research
Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?
Definitive Healthcare Corp. (DH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
2023-10-16 16:05:00 - GlobeNewsWire
Definitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2023, on Thursday, November 2, 2023 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
2023-09-12 10:00:20 - Seeking Alpha
Definitive Healthcare: Fundamentals Remain Sound But Stock Sentiment Is Bad
DH Q2 results were solid, with revenue in line and adjusted EBITDA slightly ahead. The company's near-term outlook is uncertain due to macroeconomic factors and extended sales cycles. Despite short-term challenges, the company's proprietary data competitive advantage positions it for long-term growth.
2023-09-05 16:05:00 - GlobeNewsWire
Definitive Healthcare to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
FRAMINGHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 21st Annual Global Healthcare Conference.
2023-08-14 22:24:02 - Seeking Alpha
Definitive Healthcare Corp. (DH) Q2 2023 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - Chief Executive Officer Jason Krantz - Founder and Executive Chairman Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Matt Shea - Needham & Company Brian Peterson - Raymond James Allen Lutz - Bank of America David Grossman - Stifel Jonathan Yong - Credit Suisse George Hill - Deutsche Bank Operator Welcome to the Definitive Healthcare Q2 2023 Earnings Call. Our host for today's call is Robert Musslewhite.
2023-08-11 08:32:08 - Zacks Investment Research
3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised ahead of their earnings release.